Benefits of Latent Artificial Intelligence Technologies for Patient Health: A Comprehensive Review

Authors

  • Nataraj Palaniyappan Scientist, Novitium Pharma LLC, New Jersey, USA Author
  • Vijayakumar Murugesan Research Scholar, School of Pharmacy, JSS Academy of Higher Education and Research, Mauritius Author
  • Kannan Arumugam Research Scholar, School of Pharmacy, JSS Academy of Higher Education and Research, Mauritius Author
  • M. Ravisankar Department of Pharmaceutical Chemistry, Srinivasan College of Pharmaceutical Science, Trichy Author

DOI:

https://doi.org/10.30904/j.ajcpr.2026.5047

Keywords:

latent artificial intelligence, generative models, variational autoencoders, precision medicine, clinical decision support, patient outcomes

Abstract

Latent artificial intelligence (AI) is transforming the way healthcare data are analyzed by helping computers in learning meaningful patterns from complex clinical information. Generally traditional AI models depend on directly visible features whereas latent AI learns hidden representations from medical images, electronic health records, molecular data, and physiological signals. This helps in identification of patterns that cannot be easily detected through traditional analytical methods. This review brings together findings from peer-reviewed studies published mainly between 2020 and 2026 to observe the clinical uses, benefits, and current limitations of major latent AI approaches like variational autoencoders, generative adversarial networks, latent diffusion models, and latent world models. The evidence shows that these models can help in improving diagnostic accuracy, particularly in medical imaging, generate realistic synthetic data while protecting patient privacy, supporting precision medicine and drug discovery through latent-space molecular design, and strengthening risk prediction using electronic health records and wearable devices. These developments have the potential to support early diagnosis, identify patients who may benefit from modified treatments, reduce the burden of routine clinical responsibilities, and help in rapid development of new therapies. At the same time, important challenges like limited model interpretability, the risk of algorithmic bias, regulatory concerns, and the need for stronger validation in diverse patient populations are still present. Overall, latent AI has the potential to become a valuable tool in modern healthcare when developed and applied with transparency, careful validation, fairness, and appropriate clinical oversight.

Downloads

Published

2026-05-31

Issue

Section

Articles

How to Cite

Nataraj Palaniyappan, Vijayakumar Murugesan, Kannan Arumugam, & M. Ravisankar. (2026). Benefits of Latent Artificial Intelligence Technologies for Patient Health: A Comprehensive Review. Asian Journal of Chemical and Pharmaceutical Research, 14(01), 01-08. https://doi.org/10.30904/j.ajcpr.2026.5047